Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NimbleGen gives Roche entry into microarrays

This article was originally published in Clinica

Executive Summary

Roche Diagnostics is poised to enter the microarray systems market after signing a definitive agreement to purchase high-density DNA microarray developer NimbleGen Systems in a $272.5m deal. The merger will see NimbleGen (Madison, Wisconsin) develop and market array systems through Roche's diagnostics arm Roche Applied Science (RAS), whilst also expanding its portfolio to include higher density arrays, integrated instrument systems and related reagents for advanced genome analysis.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT048950

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel